US 2011/0034425 A1Published application

Method of Treatment for Acute Myelogenous Leukemia

AssigneeUniversity of Medicine and Dentistry of New Jersey

InventorRoger Strair

Life of this patent

Estimating the term…

Abstract

This invention relates to a method of treating acute myelogenous leukemia with TPA along with Dexamethasone and choline magnesium trisalicylate.

Claims1

Dependent claims

A method of treating a patient suffering from acute myelogenous leukemia which comprises administering to the patient an effective amount of TPA along with dexamethasone and choline magnesium trisalicylate.

Dependencies are inferred from the claim text.

Facts

Application: 12/849,926Filed 4 Aug 2010
Priority: 4 Aug 2009
Published: 10 Feb 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/573
Substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone: substituted in position 21, e.g. cortisone,…
A61K 31/21
Medicinal preparations containing organic active ingredients: esters, e.g. nitroglycerine, selenocyanates
A61K 31/60
Medicinal preparations containing organic active ingredients: salicylic acid; Derivatives thereof
A61P 35/02
Antineoplastic agents: specific for leukemia

Family

Application61/273,446Us provisional application · filed 4 Aug 2009
US 8,575,216 B2Related patent
US 2011/0034425 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…